Cotadutide

Cotadutide is a medication used to treat chronic kidney disease (CKD) in adults. It is a synthetic analog of the hormone vasopressin, which is naturally produced by the pituitary gland. Cotadutide works by reducing the amount of water that the kidneys excrete, thereby helping to lower blood pressure and reduce the workload on the heart. This can be particularly beneficial for patients with CKD who are at risk of fluid overload and heart failure.

Cotadutide is administered as a subcutaneous injection, typically once daily. The dosage is usually titrated based on the patient's response to the medication, with the goal of achieving a stable blood pressure and reducing the need for other antihypertensive medications. Common side effects of cotadutide include headache, dizziness, and nausea. Serious side effects, such as seizures and allergic reactions, are rare but can occur.

Cotadutide was approved by the U.S. Food and Drug Administration (FDA) in 2014. It is marketed under the brand name Vasotect and is available in various countries around the world. The medication is typically prescribed for patients with CKD stages 3 to 5 who are at high risk of fluid overload and heart failure. It is important for patients to work closely with their healthcare providers to monitor their condition and adjust their treatment plan as needed.